Skip to main content
. 2017 Dec 15;9(14):11441–11450. doi: 10.18632/oncotarget.23571

Figure 2. CD10 expression was not associated with overall survival (OS) in all MCL patients.

Figure 2

(A), but predicted a worse OS in patients with Ki-67> 60% (B), patients with blastoid/pleomorphic morphology (C), and in patients with high MIPI (D).